Recent advances in therapy for refractory congestive heart failure.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D006328:Cardiac Catheterization; D009202:Cardiomyopathies / Q000150:complications; D003918:Dextrothyroxine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology; D006331:Heart Diseases / Q000601:surgery; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D000451:Mineralocorticoid Receptor Antagonists; D010138:Pacemaker, Artificial
D000305:Adrenal Cortex Hormones; D004071:Digitalis Glycosides; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D000628:Aminophylline; D008353:Mannitol; D003918:Dextrothyroxine; D005665:Furosemide; D005934:Glucagon; D007545:Isoproterenol; D004976:Ethacrynic Acid; D004298:Dopamine